A new Government-funded study is set to investigate the potential long-term negative effects of vaping. The research will recruit 200 individuals aiming to quit smoking and 40 non-smokers to conduct an in-depth examination of how vaping impacts the respiratory system over a year. While the NHS continues to endorse e-cigarettes as a smoking cessation aid, concerns are growing regarding non-smoking youth taking up vaping.
Although extensive research on the harmful effects of tobacco has been amassed over decades, there is limited evidence on the prolonged consequences of vaping. The Medical Research Council is now financing a £1.5 million trial to analyze the impact of vaping on lung cells, immune cells, inflammatory markers, and the “airway microbiome.”
Professor David Thickett, leading the EVALUATE study at Birmingham University, emphasized the importance of this research in understanding the safety of vaping as a short-term smoking cessation method and the potential risks associated with long-term usage. The study will delve into how e-cigarettes alter gene and protein expression over time.
Chief investigator Dr. Aaron Scott highlighted that the study will focus on the effects of vaping on crucial airway immune cells and epithelial cells in the lungs, providing valuable insights into lung health given their role in smoking-related lung diseases.
Recent reports from a major heart conference in Madrid expressed concerns about a “vaping epidemic,” with suggestions that e-cigarettes could elevate stroke risk by a third. Top heart expert Prof. Maja-Lisa Løchen urged for restrictions on e-cigarette sales to prevent a potential surge in health issues.
A review by University College London revealed a significant increase in vaping rates among adults and young adults, illustrating the rising popularity of e-cigarettes. The trial aims to recruit 200 healthy smokers from Birmingham NHS Foundation Trust’s NHS stop smoking services, with half using nicotine patches or gum for smoking cessation and the other half utilizing e-cigarettes. Additionally, 40 non-smokers will be included for comparison, with samples collected over a year to evaluate lung health.
Dr. Mike Cox, an expert in the respiratory microbiome, emphasized the project’s significance in understanding how vaping affects the airway microbiome and its evolution over time. Co-author Dr. Dhruv Parekh highlighted the comprehensive approach of studying immune cells from blood and airways to assess the impact of vaping on airway health.
ASH charity reiterated that smoking poses greater risks compared to vaping, estimating that millions have successfully quit smoking using e-cigarettes. Norway recently lifted its ban on nicotine-containing vapes, allowing regulated sales with restrictions on flavored liquids.
To participate in the study, individuals can reach out to University Hospitals Birmingham NHS staff smoking cessation services via the provided contact email.